1,563 results on '"Khan, Muhammad Shahzeb"'
Search Results
52. Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
53. Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations
54. Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency
55. Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA
56. Management of Heart Failure With Reduced Ejection Fraction in Patients With Diabetes Mellitus and Chronic Kidney Disease
57. Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials
58. Medication-Attributable Adverse Events in Heart Failure Trials
59. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
60. Trends in prevalence of comorbidities in heart failure clinical trials
61. Combustion and emission characterization of upgraded biomass fast pyrolysis oil in a swirl burner
62. CuO-decorated MOF derived ZnO polyhedral nanostructures for exceptional H2S gas detection
63. The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
64. Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States
65. Metal-organic framework-based smart nanoplatforms for biosensing, drug delivery, and cancer theranostics
66. Synergistic effects of doping, composite formation, and nanotechnology to enhance the photocatalytic activities of semiconductive materials
67. Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review
68. Preload Reduction Therapies in Heart Failure
69. Percutaneous repair of moderate‐to‐severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE‐HF2 trial and comparison to COAPT and MITRA‐FR trials
70. Prevalence and Predictors of Readmissions Among Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter
71. The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging
72. Trends in Heart Failure–Related Mortality Among Older Adults in the United States From 1999-2019
73. Cellulose and its derivatives, coffee grounds, and cross-linked, β-cyclodextrin in the race for the highest sorption capacity of cationic dyes in accordance with the principles of sustainable development
74. A Systematic Review of Sex-Specific Reporting in Heart Failure Clinical Trials: Trial Flow and Results
75. Subjective Financial Hardship due to Medical Bills Among Patients With Heart Failure in the United States: The 2014–2018 Medical Expenditure Panel Survey
76. Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018
77. Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial
78. Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure
79. Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
80. Mental health disorders and readmissions following acute myocardial infarction in the United States
81. Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes
82. The effect of preheating of a viscous and non-Newtonian bioliquid on its internally mixed twin-fluid atomization
83. Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018
84. Role of anti‐obesity drugs in heart failure regardless of ejection fraction.
85. Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
86. High electron mobility due to extra π-conjugation in the end-capped units of non-fullerene acceptor molecules: a DFT/TD-DFT-based prediction
87. Theoretical designing of selenium heterocyclic non-fullerene acceptors with enhanced power conversion efficiency for organic solar cells: a DFT/TD-DFT-based prediction and understanding
88. Association of diabetes‐specific heart failure risk score with presence of subclinical cardiomyopathy among individuals with diabetes: A prospective study
89. Efficient electrocatalytic oxygen evolution by nano NiO-In 2 O 3 electrode materials
90. The effect of sodium–glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta‐analysis
91. Why do clinicians not prescribe quadruple medical therapy for heart failure with reduced ejection fraction?
92. Kidney involvement in transthyretin cardiac amyloidosis – Role of urinary albumin to creatinine ratio and need for further evidence generation
93. Preload Reduction Therapies in Heart Failure
94. Disparities in heart failure between White, Black, and Hispanic young adults: insights from the National Health and Nutrition Examination Survey
95. Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults
96. Meta-analysis of effect of vegetarian diet on ischemic heart disease and all-cause mortality
97. Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review
98. Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
99. Percutaneous Mitral Valve Annuloplasty in Patients With Secondary Mitral Regurgitation and Severe Left Ventricular Enlargement
100. Clinical and Economic Burden of Stroke Among Young, Midlife, and Older Adults in the United States, 2002-2017
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.